CastleArk Management »

Ascendis Pharma AS shares owned by CastleArk Management

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by CastleArk Management from 13F filings

Historical chart of CastleArk Management investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by CastleArk Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by CastleArk Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $17M 62k 266.72

More positions owned by CastleArk Management

NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Lam Research Corp Com New (LRCX)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Spdr Series Trust St Inter Bd Etf (SPIB)
Visa Com Cl A (V)
Arista Networks Com Shs (ANET)
Ishares Tr Us Treas Bd Etf (GOVT)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Advanced Micro Devices (AMD)
Gilead Sciences (GILD)
Amazon (AMZN)

View all positions for CastleArk Management

Top funds holding Ascendis Pharma AS

RA Capital Management
venBio Select Advisor
Westfield Capital Management Company
Jupiter Topco
FMR
Artisan Partners Limited Partnership
BlackRock
Capital Research and Management Company - Division 3
Massachusetts Financial Services
Franklin Resources
Wellington Management Company
T. Rowe Price Associates
American Century Companies
Perceptive Advisors
Principal Financial Group

View all funds holding Ascendis Pharma AS